Contribution of the human parainfluenza virus type 3 HN-receptor interaction to pathogenesis in vivo

Journal of Virology

Volumn 75, Issue 24, 2001, Pages 12446-12451

  Prince, G A ^a   Ottolini, M G ^a   Moscona, A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HN PROTEIN; HYBRID PROTEIN; RECEPTOR; SIALIC ACID; SIALIDASE; VIRUS GLYCOPROTEIN;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRONCHIOLITIS; DISEASE SEVERITY; ENZYME ACTIVITY; GENE MUTATION; INTERSTITIAL PNEUMONIA; LUNG ALVEOLITIS; NONHUMAN; PARAINFLUENZA VIRUS 3; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RAT; VIRUS ISOLATION; VIRUS PARTICLE; VIRUS PATHOGENESIS; VIRUS REPLICATION;

ANIMALS; GUANIDINES; LUNG; NEURAMINIDASE; NOSE; PARAINFLUENZA VIRUS 3, HUMAN; PYRANS; RECEPTORS, VIRUS; RESPIROVIRUS INFECTIONS; SIALIC ACIDS; SIGMODONTINAE; VIRUS REPLICATION; ZANAMIVIR;

EID: 0035199202     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.24.12446-12451.2001     Document Type: Article

References (26)

1. Structure and diversity of infuenza virus neuraminidase
2. Crystal structure of the multifunctional paramyxovirus hemagglutinin-neuraminidase
3. The anti-influenza virus agent 4-GU-DANA (Zanamivir) inhibits cell fusion mediated by human parainfluenza virus and influenza virus HA
4. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children
5. Biological activity of paramyxovirus fusion proteins: Factors influencing formation of syncytia
6. Functional interactions between the fusion protein and hemagglutinin-neuraminidase of human parainfluenza viruses
7. The hemagglutinin-neuraminidase of human parainfluenza virus type 3: Role of the neuraminidase in the viral life cycle
8. Paramyxovirus fusion: A hypothesis for changes
9. The use of a quantitative fusion assay to evaluate HN-receptor interaction for human parainfluenza virus type 3
10. Influenza type A virus neuraminidase does not play a role in viral entry, replication, assembly, or budding
11. Fusion properties of cells persistently infected with human parainfluenza virus rope 3: Participation of hemagglutinin-neuraminidase in membrane fusion
12. Relative affinity of the human parainfluenza virus type 3 hemagglutinin-neuraminidase for sialic acid correlates with virus-induced fusion activity
13. Fusion properties of cells infected with human parainfluenza virus type 3: Receptor requirements for viral spread and virus-mediated membrane fusion
14. Analysis of human parainfluenza virus 3 receptor binding variants: Evidence for the use of a specific sialic acid-containing receptor
15. A single amino acid alteration in the human parainfluenza virus type 3 hemagglutinin-neuraminidase glycoprotein confers resistance to the inhibitory effects of Zanamivir on receptor binding and neuraminidase activity
16. An influenza A virus containing influenza B virus 5′ and 3′ noncoding regions on the neuraminidase gene is attenuated in mice
17. Human parainfluenza virus type 3 HN-receptor interaction: Effect of 4-guanidino-neu5Ac2en on a neuraminidase-deficient variant
18. Pathogenesis of human parainfluenza virus 3 infection in two species of cotton rats: Sigmodon hispidus develops bronchiolitis, while Sigmodon fulviventer develops interstitial pneumonia
19. Treatment of parainfluenza virus type 3 bronchiolitis and pneumonia in a cotton rat model using topical antibody and glucocorticosteroid
20. Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton rat
21. Effectiveness of topically administered neutralizing antibodies in experimental immunotherapy of respiratory syncytial virus infection in cotton rats
22. Pulmonary lesions in primary respiratory syncytial virus infection, reinfection and vaccine-enhanced disease in the cotton rat (Sigmodon hispidus)
23. Monophosphoryl lipid A adjuvant reverses a principal histologic parameter of formalin-inactivated respiratory syncytial virus vaccine-induced disease
24. A single amino acid substitution in the hemagglutinin-neuraminidase of Newcastle disease virus results in a protein deficient in both functions
25. Biological consequences of neuraminidase deficiency in Newcastle disease virus
26. Rational design of potent sialidase-based inhibitors of influenza virus replication